Adebrelimab Combined With Neoadjuvant Chemotherapy in Borderline Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

​ Conditions: Esophageal Squamous Cell Carcinoma (ESCC)

Interventions: Drug: Adebrelimab Injection

Sponsors: Sun Yat-sen University

Recruiting Conditions: Esophageal Squamous Cell Carcinoma (ESCC)
Interventions: Drug: Adebrelimab Injection
Sponsors: Sun Yat-sen University
Recruiting